Keywords: amgen, completes, avidia, acquisition, following, anti-trust, authority
Amgen completes Avidia acquisition
Article | 30 October 2006
Following anti-trust authority appproval, leading biotechnology firm Amgen has announced the completion of its acquisition of Avidia, a privately-held biopharmaceutical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
